Home
About
- Overview
- Team
- Investors
Science
Pipeline
Partners
News & Events
Contact
Menu Menu

NRG raises $67M to test mitochondrial pore inhibitor in ALS

8 September 2025

BioWorld

Read more
(behind a paywall)

https://www.nrgtherapeutics.com/wp-content/uploads/2026/08/NRG-Therapeutics-ounding-team-in-lab.jpg 1000 1500 Webadm https://www.nrgtherapeutics.com/wp-content/uploads/2026/07/NRG_Logo.png Webadm2025-09-08 08:05:422026-09-09 17:39:46NRG raises $67M to test mitochondrial pore inhibitor in ALS

© NRG Therapeutics

Terms & Conditions
Privacy Policy

A UK biotech takes aim at Parkinson’s, ALS by drugging mitochondria

NRG Therapeutics: Restoring motor neuron function via mitochondria